Literature DB >> 1087867

Rickets associated with anticonvulsant therapy in children with tuberous sclerosis.

D P Addy.   

Abstract

Five children with tuberous sclerosis and anti-convulsant-associated rickets have been seen in a general paediatric clinic over the last 5 years. It is suggested that vitamin D prophylaxis is particularly indicated in patients with tuberous sclerosis taking anticonvulsant medication.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1087867      PMCID： PMC1546159          DOI： 10.1136/adc.51.12.972

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Serum proteins and serum enzymes in tuberous sclerosis.

Authors:  A T Rundle; C V Fannin; K Bartlett
Journal:  J Ment Defic Res       Date:  1967-06

2.  [Osteopathies in antiepileptic long-term therapy (preliminary report)].

Authors:  R Kruse
Journal:  Monatsschr Kinderheilkd       Date:  1968-06

3.  Altered calcium metabolism due to anticonvulsant drugs.

Authors:  K De Luca; R E Masotti; M W Partington
Journal:  Dev Med Child Neurol       Date:  1972-06       Impact factor: 5.449

4.  Serum proteins and alkaline phosphatase levels in patients with tuberous sclerosis.

Authors:  M H Fischer; J S Fortune; T Gerritsen
Journal:  Am J Ment Defic       Date:  1974-05

5.  Prevalence and treatment of vitamin D deficiency in children on anticonvulsant drugs.

Authors:  J Silver; T J Davies; E Kupersmitt; M Orme; A Petrie; F Vajda
Journal:  Arch Dis Child       Date:  1974-05       Impact factor: 3.791

6.  [Disturbance of ossification in anticonvulsant long-term-treatment (author's transl)].

Authors:  W Stögmann
Journal:  Padiatr Padol       Date:  1971
  6 in total
  1 in total

1.  Calcitriol Reverses the Down-Regulation Pattern of Tuberous Sclerosis Complex Genes in an In Vitro Calcification Model.

Authors:  Eraldo Fonseca Dos Santos Junior; Roberta Rodrigues de Lemos Gitirana; Darlene Paiva Bezerra; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2017-12-11       Impact factor: 3.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.